Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore P Rasmussen

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Plos One|February 10, 2017
A standardized human embryoid body platform for the detection and analysis of teratogensAnthony Flamier, Supriya Singh, Theodore P Rasmussen
Current Protocols in Toxicology|March 8, 2018
Use of Human Embryoid Bodies for TeratologyAnthony Flamier, Supriya Singh, Theodore P Rasmussen
Methods in Molecular Biology (Clifton, N.J.)|February 6, 2013
Quantitation of nucleosome acetylation and other histone posttranslational modifications using microscale NU-ELISABo Dai, Charles Giardina, Theodore P Rasmussen
Journal of Clinical and Translational Hepatology|September 11, 2015
Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver InjuryWinfried Krueger, Urs A Boelsterli, Theodore P Rasmussen
Current Opinion in Toxicology|October 12, 2019
Variability in expression of the human MDR1 drug efflux transporter and genetic variation of the <i>ABCB1</i> gene: implications for drug-resistant epilepsyAnna Heinrich, Xiao-Bo Zhong, Theodore P Rasmussen
Experimental Cell Research|August 10, 2020
Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylationSupriya K Singh, Raman Bahal, Theodore P Rasmussen
The Yale Journal of Biology and Medicine|March 31, 2017
Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic DiseasesBindu Prabhakar, Xiao-Bo Zhong, Theodore P Rasmussen
Trends in Pharmacological Sciences|June 12, 2022
Belzutifan (Welireg™) for von Hippel Lindau diseaseEvan M McCabe, SooWan Lee, Theodore P Rasmussen
Expert Opinion on Therapeutic Targets|March 17, 2010
Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and developmentEvan R Barry, Gareth N Corry, Theodore P Rasmussen
Current Pharmacology Reports|November 23, 2018
Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver InjuryYifan Bao, Xiaochao Ma, Theodore P Rasmussen, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Plos One|February 10, 2017
A standardized human embryoid body platform for the detection and analysis of teratogensAnthony Flamier, Supriya Singh, Theodore P Rasmussen
Current Protocols in Toxicology|March 8, 2018
Use of Human Embryoid Bodies for TeratologyAnthony Flamier, Supriya Singh, Theodore P Rasmussen
Methods in Molecular Biology (Clifton, N.J.)|February 6, 2013
Quantitation of nucleosome acetylation and other histone posttranslational modifications using microscale NU-ELISABo Dai, Charles Giardina, Theodore P Rasmussen
Journal of Clinical and Translational Hepatology|September 11, 2015
Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver InjuryWinfried Krueger, Urs A Boelsterli, Theodore P Rasmussen
Current Opinion in Toxicology|October 12, 2019
Variability in expression of the human MDR1 drug efflux transporter and genetic variation of the <i>ABCB1</i> gene: implications for drug-resistant epilepsyAnna Heinrich, Xiao-Bo Zhong, Theodore P Rasmussen
Experimental Cell Research|August 10, 2020
Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylationSupriya K Singh, Raman Bahal, Theodore P Rasmussen
The Yale Journal of Biology and Medicine|March 31, 2017
Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic DiseasesBindu Prabhakar, Xiao-Bo Zhong, Theodore P Rasmussen
Trends in Pharmacological Sciences|June 12, 2022
Belzutifan (Welireg™) for von Hippel Lindau diseaseEvan M McCabe, SooWan Lee, Theodore P Rasmussen
Expert Opinion on Therapeutic Targets|March 17, 2010
Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and developmentEvan R Barry, Gareth N Corry, Theodore P Rasmussen
Current Pharmacology Reports|November 23, 2018
Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver InjuryYifan Bao, Xiaochao Ma, Theodore P Rasmussen, et al.
Pageof 5